, Volume 196, Issue 1, pp 33–42 | Cite as

Severe Hemoptysis Associated with Bacterial Pulmonary Infection: Clinical Features, Significance of Parenchymal Necrosis, and Outcome

  • Guillaume Carteaux
  • Damien Contou
  • Guillaume Voiriot
  • Antoine Khalil
  • Marie-France Carette
  • Martine Antoine
  • Antoine Parrot
  • Muriel Fartoukh



Severe hemoptysis (SH) associated with non-tuberculosis bacterial lower respiratory tract infection (LRTI) is poorly described, and the efficacy of the usual decision-making process is unknown. This study aimed at describing the clinical, radiological patterns, mechanism, and microbiological spectrum of SH related to bacterial LRTI, and assessing whether the severity of hemoptysis and the results of usual therapeutic strategy are influenced by the presence of parenchymal necrosis.


A single-center analysis of patients with SH related to bacterial LRTI from a prospective registry of consecutive patients with SH admitted to the intensive care unit of a tertiary referral center between November 1996 and May 2013.


Of 1504 patients with SH during the study period, 65 (4.3%) had SH related to bacterial LRTI, including non-necrotizing infections (n = 31), necrotizing pneumonia (n = 23), pulmonary abscess (n = 10), and excavated nodule (n = 1). The presence of parenchymal necrosis (n = 34, 52%) was associated with a more abundant bleeding (volume: 200 ml [70–300] vs. 80 ml [30–170]; p = 0.01) and a more frequent need for endovascular procedure (26/34; 76% vs. 9/31; 29%; p < 0.001). Additionally, in case of parenchymal necrosis, the pulmonary artery vasculature was involved in 16 patients (47%), and the failure rate of endovascular treatment was up to 25% despite multiple procedures.


Bacterial LRTI is a rare cause of SH. The presence of parenchymal necrosis is more likely associated with bleeding severity, pulmonary vasculature involvement, and endovascular treatment failure.


Hemoptysis Pulmonary vasculature Endovascular treatment Parenchymal necrosis Necrotizing pneumonia 


Compliance with Ethical Standard

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Lordan JL (2003) The pulmonary physician in critical care * Illustrative case 7: assessment and management of massive haemoptysis. Thorax 58:814–819. doi: 10.1136/thorax.58.9.814 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Mal H, Rullon I, Mellot F et al (1999) Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 115:996–1001. doi: 10.1378/chest.115.4.996 CrossRefPubMedGoogle Scholar
  3. 3.
    Knott-Craig CJ, Oostuizen JG, Rossouw G et al (1993) Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J Thorac Cardiovasc Surg 105:394–397PubMedGoogle Scholar
  4. 4.
    de Gregorio MA, Medrano J, Mainar A et al (2006) Endovascular treatment of massive hemoptysis by bronchial artery embolization: short-term and long-term follow-up over a 15-year period. Arch Bronconeumol 42:49–56CrossRefPubMedGoogle Scholar
  5. 5.
    Fartoukh M, Khalil A, Louis L et al (2007) An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre. Respir Res 8:11. doi: 10.1186/1465-9921-8-11 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Savale L, Parrot A, Khalil A et al (2007) Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med 175:1181–1185. doi: 10.1164/rccm.200609-1362OC CrossRefPubMedGoogle Scholar
  7. 7.
    Razazi K, Parrot A, Khalil A et al (2015) Severe haemoptysis in patients with nonsmall cell lung carcinoma. Eur Respir J 45:756–764. doi: 10.1183/09031936.00010114 CrossRefPubMedGoogle Scholar
  8. 8.
    Gillet Y, Vanhems P, Lina G et al (2007) Factors Predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 45:315–321. doi: 10.1086/519263 CrossRefPubMedGoogle Scholar
  9. 9.
    Gillet Y, Issartel B, Vanhems P et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet Lond Engl 359:753–759. doi: 10.1016/S0140-6736(02)07877-7 CrossRefGoogle Scholar
  10. 10.
    Boussaud V, Parrot A, Mayaud C et al (2003) Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med 29:1840–1843. doi: 10.1007/s00134-003-1918-5 CrossRefPubMedGoogle Scholar
  11. 11.
    Morgan MS (2007) Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 30:289–296. doi: 10.1016/j.ijantimicag.2007.04.019 CrossRefPubMedGoogle Scholar
  12. 12.
    Reimel BA, Krishnadasen B, Cuschieri J et al (2006) Surgical management of acute necrotizing lung infections. Can Respir J 13:369–373CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ayed A (2003) Pulmonary resection for massive hemoptysis of benign etiology. Eur J Cardiothorac Surg 24:689–693. doi: 10.1016/S1010-7940(03)00508-6 CrossRefPubMedGoogle Scholar
  14. 14.
    Thoms NW, Wilson RF, Puro HE, Arbulu A (1972) Life-threatening hemoptysis in primary lung abscess. Ann Thorac Surg 14:347–358CrossRefPubMedGoogle Scholar
  15. 15.
    Philpott NJ, Woodhead MA, Wilson AG, Millard FJ (1993) Lung abscess: a neglected cause of life threatening haemoptysis. Thorax 48:674–675CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hamer DH, Schwab LE, Gray R (1992) Massive hemoptysis from thoracic actinomycosis successfully treated by embolization. Chest 101:1442–1443. doi: 10.1378/chest.101.5.1442 CrossRefPubMedGoogle Scholar
  17. 17.
    Hsieh M-J, Liu H-P, Chang J-P, Chang C-H (1993) Thoracic actinomycosis. Chest J 104:366–370CrossRefGoogle Scholar
  18. 18.
    Ljudmila N-O, Pesut D, Stevic R, Stojsic J (2007) Uncommon pulmonary infection with recurrent hemoptysis. Chin Med J (Engl) 120:2331–2333Google Scholar
  19. 19.
    Lu M-S, Liu H-P, Yeh C-H et al (2003) The role of surgery in hemoptysis caused by thoracic actinomycosis; a forgotten disease. Eur J Cardiothorac Surg 24:694–698. doi: 10.1016/S1010-7940(03)00515-3 CrossRefPubMedGoogle Scholar
  20. 20.
    Reechaipichitkul W, Napaprasit T, Puapairoj A, Prathanee S (2005) Pulmonary actinomycosis presenting with prolonged fever and massive hemoptysis: a case report. Southeast Asian J Trop Med Public Health 36:1268–1271PubMedGoogle Scholar
  21. 21.
    Khalil A, Fartoukh M, Tassart M et al (2007) Role of MDCT in identification of the bleeding site and the vessels causing hemoptysis. Am J Roentgenol 188:W117–W125. doi: 10.2214/AJR.05.1578 CrossRefGoogle Scholar
  22. 22.
    Khalil A, Soussan M, Mangiapan G et al (2007) Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol 80:21–25. doi: 10.1259/bjr/59233312 CrossRefPubMedGoogle Scholar
  23. 23.
    Joyce SM (1986) Sputum analysis and culture. Ann Emerg Med 15:325–328CrossRefPubMedGoogle Scholar
  24. 24.
    Wu CL, Yang DI, Wang NY et al (2002) Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest 122:662–668CrossRefPubMedGoogle Scholar
  25. 25.
    Pham LH, Brun-Buisson C, Legrand P et al (1991) Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush. Am Rev Respir Dis 143:1055–1061. doi: 10.1164/ajrccm/143.5_Pt_1.1055 CrossRefPubMedGoogle Scholar
  26. 26.
    Chastre J, Fagon JY, Bornet-Lecso M et al (1995) Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 152:231–240. doi: 10.1164/ajrccm.152.1.7599829 CrossRefPubMedGoogle Scholar
  27. 27.
    Endo S, Otani S, Saito N et al (2003) Management of massive hemoptysis in a thoracic surgical unit. Eur J Cardiothorac Surg 23:467–472. doi: 10.1016/S1010-7940(03)00008-3 CrossRefPubMedGoogle Scholar
  28. 28.
    Jougon J, Ballester M, Delcambre F et al (2002) Massive hemoptysis: what place for medical and surgical treatment. Eur J Cardiothorac Surg 22:345–351CrossRefPubMedGoogle Scholar
  29. 29.
    Katoh O, Kishikawa T, Yamada H et al (1990) Recurrent bleeding after arterial embolization in patients with hemoptysis. Chest 97:541–546. doi: 10.1378/chest.97.3.541 CrossRefPubMedGoogle Scholar
  30. 30.
    Marshall TJ, Jackson JE (1997) Vascular intervention in the thorax: bronchial artery embolization for haemoptysis. Eur Radiol 7:1221–1227CrossRefPubMedGoogle Scholar
  31. 31.
    Conlan AA, Hurwitz SS, Krige L et al (1983) Massive hemoptysis. Review of 123 cases. J Thorac Cardiovasc Surg 85:120–124PubMedGoogle Scholar
  32. 32.
    Alaoui AY, Bartal M, el Boutahiri A et al (1992) Clinical characteristics and etiology in hemoptysis in a pneumology service. 291 cases. Rev Mal Respir 9:295–300PubMedGoogle Scholar
  33. 33.
    Hirshberg B, Biran I, Glazer M, Kramer MR (1997) Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 112:440–444. doi: 10.1378/chest.112.2.440 CrossRefPubMedGoogle Scholar
  34. 34.
    de Gregorio MA, Medrano J, Laborda A, Higuera T (2007) Hemoptysis workup before embolization: single-center experience with a 15-year period follow-up. Tech Vasc Interv Radiol 10:270–273. doi: 10.1053/j.tvir.2008.03.004 CrossRefPubMedGoogle Scholar
  35. 35.
    Khalil A, Parrot A, Nedelcu C et al (2008) Severe hemoptysis of pulmonary arterial origin: signs and role of multidetector row CT angiography. Chest 133:212–219. doi: 10.1378/chest.07-1159 CrossRefPubMedGoogle Scholar
  36. 36.
    Yu-Tang Goh P, Lin M, Teo N, En Shen Wong D (2002) Embolization for hemoptysis: a six-year review. Cardiovasc Interv Radiol 25:17–25. doi: 10.1007/s00270-001-0047-1 CrossRefGoogle Scholar
  37. 37.
    Ong T-H, Eng P (2003) Massive hemoptysis requiring intensive care. Intensive Care Med 29:317–320. doi: 10.1007/s00134-002-1553-6 CrossRefPubMedGoogle Scholar
  38. 38.
    Kato A, Kudo S, Matsumoto K et al (2000) Bronchial artery embolization for hemoptysis due to benign diseases: immediate and long-term results. Cardiovasc Interv Radiol 23:351–357. doi: 10.1007/s002700010062 CrossRefGoogle Scholar
  39. 39.
    Ramakantan R, Bandekar VG, Gandhi MS et al (1996) Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology 200:691–694CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Assistance Publique-Hôpitaux de Paris, Groupe Henri Mondor-Albert Chenevier, Service de Réanimation MédicaleCHU Henri MondorParisFrance
  2. 2.Faculté de Médecine de Créteil, Groupe de recherche clinique CARMASUniversité Paris Est CréteilParisFrance
  3. 3.Service de reanimation polyvalenteCentre Hospitalier d’ArgenteuilParisFrance
  4. 4.Assistance Publique-Hôpitaux de Paris, Unité de Réanimation médico-chirurgicale, Groupe hospitalier des Hôpitaux Universitaires de l’Est ParisienHôpital TenonParisFrance
  5. 5.Assistance Publique-Hôpitaux de Paris, Service d’Imagerie Médicale, Groupe Hospitalier des Hôpitaux Universitaires de l’Est ParisienHôpital TenonParisFrance
  6. 6.Assistance Publique-Hôpitaux de Paris, Service d’Imagerie MédicaleHôpital Bichat-Claude-BernardParisFrance
  7. 7.Université Paris 07ParisFrance
  8. 8.Sorbonne UniversitésUPMC Université Paris 06ParisFrance
  9. 9.Assistance Publique-Hôpitaux de Paris, Service d’anatomopathologie, Groupe Hospitalier des Hôpitaux Universitaires de l’Est ParisienHôpital TenonParisFrance

Personalised recommendations